US › Healthcare

Scienture Holdings, Inc. (SCNX)

US · Healthcare · Pharmaceutical Retailers

$3.36-0.59%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$343,639

Net profit

$-2.8M

EPS

$-0.07

EPS estimate

$-0.09

Net margin

-821.3%

EPS came in at -0.07 against a street estimate of -0.09 — a beat of 22.2%.

Key statistics

Market cap

$5.3M

Forward P/E

21.8

P/B

0.19

Book value

$39.02

EPS (TTM)

$-52.75

52-week high

$65.00

52-week low

$3.23

50-day MA

$8.43

200-day MA

$9.89

Beta

4.08

Analyst view

Analysts rate Scienture Holdings, Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $37.50.

Shareholding

Insiders

22.08%

Institutions

5.30%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.26%
Geode Capital Management, LLC	0.82%
Susquehanna International Group, LLP	0.58%
Vanguard Fiduciary Trust Co	0.49%
Citadel Advisors Llc	0.41%
HRT FINANCIAL LLC	0.33%
XTX Topco Ltd	0.26%
Northern Trust Corp	0.22%

Corporate actions

Action	Detail	Date
Split	1 : 25 effective Oct 5, 2026	2026-10-05

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Scienture Holdings, Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.